Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
Archive ouverte
El-Deiry, Wafik, S | Bresson, Catherine | Wunder, Fanny | Carneiro, Benedito, A | Dizon, Don, S | Warner, Jeremy, L | Graff, Stephanie, L | Azzoli, Christopher, G | Wong, Eric, T | Cheng, Liang | Mani, Sendurai, A | Safran, Howard, P | Williams, Casey | Meissner, Tobias | Solomon, Benjamin | Rubin, Eitan | Porgador, Angel | Berchem, Guy | Saintigny, Pierre | Onn, Amir | Bar, Jair | Berger, Raanan | Gantenbein, Manon | Chen, Zhen | De, Cristiano | Souza, Pádua | Manuel, Rui | Reis, Vieira | Sekacheva, Marina | Cervantes, Andrés | Dahut, William, L | Annunziata, Christina, M | Gober, Kerri | Musallam, Khaled, M | Al-Shamsi, Humaid, O | Abu-Gheida, Ibrahim | Salazar, Ramon | Limaye, Sewanti | Aref, Adel, T | Reddel, Roger, R | Ussama, Mohammed | Homsi, Al | Rouf, Abdul | Al Suwaidi, Jassim | Vlad, Catalin | Buiga, Rares | Al Omari, Amal | Abdel-Razeq, Hikmat | Oñate-Ocaña, Luis, F | Finn, Cilius | Graham, Leah | Rueter, Jens | Joshua, Anthony, M | Girda, Eugenia | Libutti, Steven | Riedlinger, Gregory | Salem, Mohammed, E | Farhangfar, Carol, J | Mesa, Ruben, A | Faltas, Bishoy, M | Elemento, Olivier | Pramesh, C, S | Sengar, Manju | Aoyama, Satoru | Ikeda, Sadakatsu | Berindan-Neagoe, Ioana | Gaddipati, Himabindu | Kulkarni, Mandar | Auzias, Elisabeth | Gerogianni, Maria | Wolikow, Nicolas | Istolainen, Simon | Schlafrig, Pessie | Frankel, Naftali, Z | Ferraro, Amanda, R | Palma, Jim | Piris Gimenez, Alejandro | Hernando-Calvo, Alberto | Felip, Enriqueta | Tsimberidou, Apostolia, M | Herbst, Roy, S | Tabernero, Josep | Schilsky, Richard, L | Liu, Jia | Lussier, Yves | Raynaud, Jacques | Batist, Gerald | Magidi, Shai | Kurzrock, Razelle | Chair, R | Kurzrock, Win | Consortium, France | El-Deiry, Win, W S | Berger, Sheba, R | Medical Center, Israel | Hadfield, M | Co-Moderator, Community | Saintigny Centre, Léon, P | Bérard, France | Abdel, H | Basik, M | Braña, I
Edité par
CCSD ; Impact journals -
International audience.
WIN's MTB leadership is constituted by both precision oncology and disease experts to guide the discussion.
